• 1
    Cutler JA, Sorlie PD, Wolz M, et al. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988–1994 and 1999–2004. Hypertension. 2008;52:818827.
  • 2
    Fields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398404.
  • 3
    Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510e526.
  • 4
    Kaplan NM. Resistant hypertension. J Hypertens. 2005;23:14411444.
  • 5
    Pimenta E. Update on diagnosis and treatment of resistant hypertension. Iran J Kidney Dis. 2011;5:215227.
  • 6
    Pimenta E, Gaddam KK, Oparil S, et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009;54:475481.
  • 7
    Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:18291836.
  • 8
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:13781384.
  • 9
    Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab. 2010;24:731743.
  • 10
    Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19:22712277.
  • 11
    Narkiewicz K, Wolf J, Lopez-Jimenez F, Somers VK. Obstructive sleep apnea and hypertension. Curr Cardiol Rep. 2005;7:435440.
  • 12
    Gislason T, Aberg H, Taube A. Snoring and systemic hypertension – an epidemiological study. Acta Med Scand. 1987;222:415421.
  • 13
    Bansil P, Kuklina EV, Merritt RK, Yoon PW. Associations between sleep disorders, sleep duration, quality of sleep, and hypertension: results from the National Health and Nutrition Examination Survey, 2005 to 2008. J Clin Hypertens (Greenwich). 2011;13:739743.
  • 14
    Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 20052008. Accessed December 5, 2010.
  • 15
    Stamatakis KA, Kaplan GA, Roberts RE. Short sleep duration across income, education, and race/ethnic groups: population prevalence and growing disparities during 34 years of follow-up. Ann Epidemiol. 2007;17:948955.
  • 16
    National Center on Sleep Disorders Research. Insomnia: Assessment and Management in Primary Care. NIH Pub No 98-4088. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 1998.
  • 17
    Emmons KM, Abrams DB, Marshall R, et al. An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposure. Prev Med. 1994;23:3539.
  • 18
    National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – the evidence report. Obes Res. 1998;6(suppl 2):51S209S.
  • 19
    American Diabetes Association. Executive summary: standards of medical care in diabetes – 2011. Diabetes Care. 2011;34(suppl 1):S4S10.
  • 20
    Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606613.
  • 21
    Rust K. Variance estimation for complex estimation in sample surveys. J Off Stat. 1985;1:381397.
  • 22
    Delgado JL, Johnson CL, Roy I, Treviño FM. Hispanic Health and Nutrition Examination Survey: methodological considerations. Am J Public Health 1990 Dec;80Suppl:610.
  • 23
    Patel SR, Ayas NT, Malhotra MR, White DP, Schernhammer ES, Speizer FE, Stampfer MJ, Hu FB. A prospective study of sleep duration and mortality risk in women. Sleep 2004;27:440444.
  • 24
    Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich). 2002;4:393404.
  • 25
    Bakris GL. A practical approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med. 2001;161:26612667.
  • 26
    Williams GH. Assessing patient wellness: new perspectives on quality of life and compliance. Am J Hypertens. 1998;11:186S191S.
  • 27
    Goodfriend TL, Calhoun DA. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension. 2004;43:518524.
  • 28
    Goncalves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007;132:18581862.
  • 29
    Koskenvuo M, Kaprio J, Partinen M, et al. Snoring as a risk factor for hypertension and angina pectoris. Lancet. 1985;1:893896.
  • 30
    Koskenvuo M, Partinen M, Kaprio J, et al. Snoring and cardiovascular risk factors. Ann Med. 1994;26:371376.
  • 31
    Stradling JR, Crosby JH. Relation between systemic hypertension and sleep hypoxaemia or snoring: analysis in 748 men drawn from general practice. BMJ. 1990;300:7578.